Episodes in action: linking the cost and quality of nonsurgical coronary revascularization

M Pine1

  • 1Michael Pine and Associates, Inc., University of Chicago, Chicago, Illinois, USA.

Managed Care Quarterly
|September 15, 2001
PubMed

Insights

Financial incentives can reward quality healthcare by analyzing four risk types. This study shows incentives favor providers delivering appropriate, effective, and efficient patient care.

Area of Science:

  • Health Economics
  • Medical Informatics
  • Healthcare Management

Background:

  • Financial incentives in healthcare can influence provider behavior and care quality.
  • Current payment models may not adequately reward clinical judgment, technical skill, or efficiency.
  • Understanding the relationship between performance and financial outcomes is crucial for healthcare reform.

Purpose of the Study:

  • To explore the creation of financial incentives by dissociating healthcare episodes into distinct risk categories.
  • To analyze the relationship between clinical performance and financial success in nonsurgical coronary revascularization.
  • To determine if financial incentives favor providers of high-quality, efficient care.

Main Methods:

  • A computer-generated simulation of 100,000 percutaneous transluminal coronary angioplasty (PTCA) episodes was utilized.
  • Global fees were assigned to each patient episode.
  • The study assessed 100 hypothetical practices to evaluate clinical performance and financial outcomes.

Main Results:

  • The study successfully dissociated episodes into four risk types: occurrence, clinical, technical, and utility risk.
  • High sensitivity and specificity were achieved in assessing clinical performance.
  • Financial incentives were demonstrated to favor providers delivering appropriate, effective, and efficient care.

Conclusions:

  • Dissociating healthcare episodes into specific risk types allows for targeted financial incentives.
  • These incentives can effectively reward good clinical judgment, superior technical quality, and efficient healthcare delivery.
  • The findings support the use of performance-based financial models to promote high-value healthcare.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...